id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
cord-296683-fjn29oal	Sarode, Sachin C	Oral submucous fibrosis and COVID-19: Perspective on comorbidity	2020-05-21		.txt	text/plain	967	44	46	key: cord-296683-fjn29oal authors: Sarode, Sachin C; Sarode, Gargi S; Gondivkar, Shailesh; Gadbail, Amol; Gopalkrishnan, Dharmarajan; Patil, Shankargouda title: Oral submucous fibrosis and COVID-19: Perspective on comorbidity date: 2020-05-21 journal: Oral Oncol DOI: 10.1016/j.oraloncology.2020.104811 sha: doc_id: 296683 cord_uid: fjn29oal nan Funding source: None declared. Physiological and pathological regulation of ACE2, the SARS-CoV-2 receptor SARS and MERS: recent insights into emerging coronaviruses High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa Angiotensin II revisited: new roles in inflammation, immunology and aging A novel angiotensin-converting enzymerelated carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9 Loss of angiotensin-converting enzyme-2 leads to the late development of angiotensin IIdependent glomerulosclerosis Oral submucous fibrosis: a case-control study in Chennai, South India Angiotensin-converting enzyme gene insertion/deletion polymorphism is associated with risk of oral precancerous lesion in betel quid chewers Factors Associated With Mental Health Outcomes Among Health Care Workers Exposed to Coronavirus Disease Oral submucous fibrosis: review on aetiology and pathogenesis Figure 1.	cache/cord-296683-fjn29oal.txt	txt/cord-296683-fjn29oal.txt
